Most states have taken advantage of the opportunity to expand access to Medicaid since 2014 through the Affordable Care Act. That’s helping reduce the number of uninsured people.
The Affordable Care Act has allowed many preventive health services, including cancer screenings and vaccines, to be free of charge. But legal challenges may lead to costly repercussions for patients.
The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
Often the main differences among plans involve a long list of varying deductibles, co-pays and other out-of-pocket expenses, which can be tough to analyze.
New Zealanders have, in principle, access to free healthcare. But inequality is a major issue, affecting Māori and Pasifika communities and New Zealanders living with disabilities or in poverty.
COVID-19 cases among college students are inevitable. If you’re a college student – or the parent of one – you need to know who’s going to foot the bill if they get sick.
Studies repeatedly have shown that health care in general and the high cost of drugs in particular are among the top concerns of US voters. But with coronavirus, the issue may fade from prominence.
M Niaz Asadullah, University of Malaya; Fisca Miswari Aulia, National Development Planning Agency (BAPPENAS), and Maliki, National Development Planning Agency (BAPPENAS)
COVID19 threatens to reverse years of Indonesia’s positive trends in poverty alleviation. We highlight lessons from past policies to prevent another poverty hike during the pandemic.
In the UK, nobody collects patients’ insurance information or credit card details. There’s simply no charge for services, including doctor visits, ambulances and hospitalizations.
High prescription drug costs are a widespread concern for consumers and policymakers. For patients who need specialty drugs, though, the problem is even worse, with no relief in sight.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California